Jeet Mukherjee, PhD, is a Vice President and Biotechnology Analyst at BTIG. Prior to joining BTIG, Mr. Mukherjee was a Senior Associate at Casdin Capital where he focused on public and private investments in the therapeutics space. Previously, he was a Senior Associate on the biotechnology equity research team at Jefferies. Mr. Mukherjee earned his PhD in pharmacology from Weill Cornell Medical College and his bachelor’s degree in biology from the University of Delaware.